APOO and Hyperglycemia: Transcriptomics data revealed a reduction in SLC1A5 in MIC26 KOs, whereas proteomics revealed a significant reduction in normoglycemia and non-significant reduction in hyperglycemia in MIC26 KOs compared with WT (Fig S10B and C).